Contact your healthcare provider if you experience excessive thirst with frequent urination, painful urination, blood in urine, decreased urination with dark urine, dizziness, or persistent vomiting or diarrhea that may cause dehydration
Utilizing state-of-the-art technology, our treatments provide precise, long-lasting results
Abstract The aim of this narrative review is to critically assess the renoprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in managing albuminuria among patients with type 2 diabetes mellitus within the framework of personalized medicine
If tirzepatide gets approved for additional indications like NASH, sleep apnea, CKD, heart failure, pre-diabetes, etc., it could significantly increase the market opportunity for Eli Lilly
Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice